We are an independent research institute focused on translational research into more effective, tolerable and accessible cancer treatments for all.
ONJ Cancer Research Institute
Loading...
New research led by Dr Elizabeth Goodall reveals a striking gap between clinical trial recruitment criteria and real-world cancer patients
➡️ Read the British Journal of Haematology paper: https://onlinelibrary.wiley.com/doi/10.1111/bjh.70550
#LymphomaResearch #CancerResearch #ClinicalTrials
🎉 Congratulations to postdoctoral researcher Dr Pavitha Parathan for becoming the first-ever recipient of Pancare Foundation's Eliza Wilmot Scholarship.
➡️ Read more: https://ow.ly/zJ0150Z1rF2
🎉 Congratulations to PhD student Birhanu Ayelign for receiving an Abacus Dx 2026 Emerging Investigators Grant to advance his phage therapy research in gastric cancer.
#gastriccancer #phagetherapy
A new review paper by ONJCRI researchers Anamika Saini and Dr Shiyao Li investigates how the biomolecular corona that forms on RNA-lipid nanoparticles shapes their cargo delivery behaviour.
➡️ ow.ly/mOhR50Z5rpA (ACS Nano @pubs.acs.org)
#LipidNanoparticles #Nanomedicine
Congratulations to Kaitlyn Kew on receiving a Tour de Cure PhD Scholarship 👏
Her research is on children with B-cell acute lymphoblastic leukaemia (B-ALL). With ~10% of patients experiencing relapse, this work could help drive more effective treatments.
#CancerResearch #PhD #Leukaemia
Congratulations to Prof Eliza Hawkes, her team and collaborators who received a $1.9m Cancer Australia grant to activate the iLIMM lymphoma study. Objectives:
• Advanced tumour and immune system mapping
• Testing whether physical exercise could improve outcomes
➡️ https://ow.ly/a8KN50YVmKN
#NHMRC
We are delighted to share that our 2025 Annual Report is now published and available to read ➡️️ https://ow.ly/4nWW50Z4xVA
#CancerResearch #AnnualReport
Results from ONJCRI’s MoST-CIRCUIT clinical trial suggest that combination immunotherapy with nivolumab and ipilimumab is a promising avenue for hard-to-treat gallbladder cancer patients.
➡️ https://ow.ly/RLX450YT3pI
#ClinicalTrials #GallbladderCancer #BiliaryTractCancer #immunotherapy
Congratulations to our researchers who were awarded funding from Tour de Cure to pursue innovative and impactful cancer research projects.
• Dr Bhupinder Pal
• Dr Zhipeng Cao
• Dr Rebekah Crake
➡️ Read more: https://ow.ly/HARX50YKLUi
#CancerResearch #ResearchFunding
Global cancer care faces a 100 million worker shortfall by 2050, suggests new Commission report. With coordinated investment:
📌 170 million deaths prevented
📌 $120 trillion net economic benefit
Prof Andrew Scott was a Commission co-author.
Read more in The Lancet Oncology: tinyurl.com/ysa9zv37
